Evotec SE (EVO) Interest Coverage Ratio Growth (1y) (2010 - 2025)
Evotec SE (EVO) Interest Coverage Ratio Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Evotec SE | 687.23 Mn | 686.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 92.74% |
| Dec 31, 2022 | -155.12% |
| Sep 30, 2022 | -51.62% |
| Jun 30, 2022 | 130.14% |
| Mar 31, 2022 | 31.36% |
| Dec 31, 2021 | -85.68% |
| Sep 30, 2021 | -78.04% |
| Dec 31, 2020 | -99.84% |
| Jun 30, 2010 | 113.16% |
| Mar 31, 2010 | -100.00% |